Akebia Therapeutics (AKBA) Tops Q4 EPS by 14c

Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.52), $0.14 better than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Citi expects Micron stock to rally into this event